Statins after a stroke bleed in the brain (Phase 3)
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 50 or older
- Your CT or MRI showed a spontaneous bleeding stroke in the brain’s lobar area
- You were taking a statin when the bleeding stroke started
- You can start the trial within 7 days of the bleed
- Your statin prescriber and you (or a legal representative) agree you can choose to continue or stop the statin for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.
This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.
This study looks at how well cholesterol-lowering treatments work after a recent stroke or mini-stroke. The goal is to see if optimizing cholesterol levels can help prevent future strokes.
This trial tests whether a higher-dose statin can help after an ischemic stroke in people who have specific plaque patterns in brain blood vessels. It may help lower the risk of another stroke by targeting the artery plaque process.
This trial tests whether a more intensive dose of a common cholesterol medicine (atorvastatin) increases or decreases the risk of bleeding in the brain for people who have had a stroke and also have tiny brain bleeds. It aims to find the safest and most effective way to use statins in this situation.
This trial tests whether giving statins (cholesterol-lowering medicine) to older adults who are frail and have just had a stroke or mini-stroke can help prevent another one. It is designed to see if the benefits of statins outweigh the risks in this group.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.